KETOCONAZOLE THERAPY FOR WOMEN WITH ACNE AND OR HIRSUTISM

被引:31
作者
VENTUROLI, S
FABBRI, R
DALPRATO, L
MANTOVANI, B
CAPELLI, M
MAGRINI, O
FLAMIGNI, C
机构
[1] UNIV BOLOGNA, DEPT EVOLUT EXPTL BIOL, I-40126 BOLOGNA, ITALY
[2] ST ORSOLA MARCELLO MALPIGHI HOSP, CENT LAB, BOLOGNA, ITALY
关键词
D O I
10.1210/jcem-71-2-335
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of ketoconazole, a synthetic imidazole derivate, were evaluated in 42 women affected by acne (17 cases) and/or hirsutism β6 cases) treated with 400 mg/day for 3–6 months. Androstenedione, total and free testosterone, 5adihydrotestosterone and dehydroepiandrosterone levels progressively dropped during treatment while 17α hydroxyprogesterone, estradiol, ACTH, cortisol, LH and FSH levels increased. Dehydroepiandrosterone sulfate decreased only towards the end of treatment, while estrone, sex hormone binding globulin, and PRL remained unchanged. Daily mean ± sd rate of hair growth, measured by a special image analysis processor, decreased within 3 months of therapy from 0.258 ± 0.058 to 0.184 ± 0.039 mm/day (P < 0.02) and mean ± sd hair diameter from 0.123 ± 0.015 to 0.110 ± 0.013 mm (P < 0.05) together with decreasing hormone levels. The therapeutic effects of ketoconazole on hirsutism was evident at 6 months in only 14 subjects, while no significant change in hirsutism score was recorded in 22 women who failed to complete the therapy. Acne improved in all cases. Several side effects and complications arose during treatment, such as headache, nausea, loss of scalp hair, hepatitis, and biochemical changes. Even though ketoconazole improves hyperandrogenism, only selected patients are eligible for treatment as scrupulous monitoring is required. © 1990 by The Endocrine Society.
引用
收藏
页码:335 / 339
页数:5
相关论文
共 27 条
[1]  
ANGELI A, 1985, LANCET, V1, P821
[2]   EFFECT OF KETOCONAZOLE ON PLACENTAL AROMATASE, 3-BETA-HYDROXYSTEROID DEHYDROGENASE-ISOMERASE AND 17-BETA-HYDROXYSTEROID DEHYDROGENASE [J].
AYUB, M ;
STITCH, SR .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1986, 25 (06) :981-984
[3]   HORMONAL EFFECTS OF KETOCONAZOLE INVIVO IN THE MALE-RAT - MECHANISM OF ACTION [J].
BHASIN, S ;
SIKKA, S ;
FIELDER, T ;
SODMORIAH, U ;
LEVINE, HB ;
SWERDLOFF, RS ;
RAJFER, J .
ENDOCRINOLOGY, 1986, 118 (03) :1229-1232
[4]   RESPONSE OF PITUITARY-ADRENAL AXIS TO CORTICOTROPIN RELEASING HORMONE IN PATIENTS WITH CUSHINGS-DISEASE BEFORE AND AFTER KETOCONAZOLE TREATMENT [J].
BOSCARO, M ;
SONINO, N ;
RAMPAZZO, A ;
MANTERO, F .
CLINICAL ENDOCRINOLOGY, 1987, 27 (04) :461-467
[5]  
CARVALHO D, 1985, LANCET, V2, P560
[6]   KINETIC-ANALYSIS OF INHIBITION OF HUMAN ADRENAL STEROIDOGENESIS BY KETOCONAZOLE [J].
COUCH, RM ;
MULLER, J ;
PERRY, YS ;
WINTER, JSD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (03) :551-554
[7]   UNCONJUGATED DEHYDROEPIANDROSTERONE PLASMA-LEVELS IN NORMAL SUBJECTS FROM BIRTH TO ADOLESCENCE IN HUMAN - USE OF A SENSITIVE RADIOIMMUNOASSAY [J].
DEPERETTI, E ;
FOREST, MG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 43 (05) :982-991
[8]   KETOCONAZOLE AND OTHER IMIDAZOLE DERIVATIVES AS INHIBITORS OF STEROIDOGENESIS [J].
FELDMAN, D .
ENDOCRINE REVIEWS, 1986, 7 (04) :409-420
[9]   CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN [J].
FERRIMAN, D ;
GALLWEY, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1961, 21 (11) :1440-+
[10]  
FLAMIGNI C, 1989, HIRSUTISM ENDOCRINE, P31